BamSEC and AlphaSense Join Forces
Learn More

Northwest Biotherapeutics Inc

OTC: NWBO    
Share price (12/24/24): $0.26    
Market cap (12/24/24): $337 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.7
from S-3 76 pages Northwest Biotherapeutics, Inc. and , Trustee Indenture Dated as of , 2022 Subordinated Debt Securities Northwest Biotherapeutics, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ___, 2022
12/34/56
EX-4.6
from S-3 71 pages Northwest Biotherapeutics, Inc. and , Trustee Indenture Dated as of , 2022 Senior Debt Securities Northwest Biotherapeutics, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ___, 2022
12/34/56
EX-4.1
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 63 pages Northwest Biotherapeutics, Inc. and , Trustee Indenture Dated as of , 2019 Debt Securities Northwest Biotherapeutics, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ___, 2019
12/34/56
EX-4.5
from S-3 63 pages Northwest Biotherapeutics, Inc. and , Trustee Indenture Dated as of , 2016 Debt Securities Northwest Biotherapeutics, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ___, 2016
12/34/56
EX-4.5
from S-3/A 63 pages Northwest Biotherapeutics, Inc. and , Trustee Indenture Dated as of , 2015 Debt Securities Northwest Biotherapeutics, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of ___, 2015
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Northwest Biotherapeutics, Inc
12/34/56
EX-4.1
from 8-K 120 pages Northwest Biotherapeutics, Inc., and the Bank of New York Mellon, as Trustee Indenture Dated as of August 19, 2014 5.00% Convertible Senior Notes Due 2017
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Northwest Biotherapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Northwest Biotherapeutics, Inc
12/34/56
EX-4.2
from 8-K 16 pages Over-Allotment Common Stock Purchase Warrant Northwest Biotherapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Long Term Common Stock Purchase Warrant Northwest Biotherapeutics, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Northwest Biotherapeutics, Inc
12/34/56
EX-4.5
from S-3/A 37 pages Form of Subordinated Indenture by and Between Northwest Biotherapeutics, Inc. as Issuer, and , as Trustee Dated as Of
12/34/56
EX-4.4
from S-3/A 34 pages Form of Senior Indenture by and Between Northwest Biotherapeutics, Inc. as Issuer, and , as Trustee Dated as Of
12/34/56
EX-4.2
from S-1/A 28 pages Northwest Biotherapeutics, Inc. Warrant Agency Agreement
12/34/56
EX-4.2
from 10-K ~1 page Indenture or similar
12/34/56
EX-4
from SC 13D ~20 pages Indenture or similar
12/34/56
EX-4.2
from 8-A12G ~50 pages Indenture or similar
12/34/56